Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study
Breast cancer is heterogeneous, as indicated by the fact that tumours with identical morphologic and immunohistochemical characteristics have different clinical behaviour and treatment responses. This...